Genoil (GNOLF) Operating Expenses (2009 - 2025)

Genoil (GNOLF) has 13 years of Operating Expenses data on file, last reported at $117630.0 in Q4 2025.

• On a quarterly basis, Operating Expenses fell 92.41% year-over-year to $117630.0 in Q4 2025; TTM through Dec 2025 was $626092.0, a 68.83% decrease from a year earlier, with the FY2025 full-year figure at $626092.0, down 68.83% from the prior year.
• Operating Expenses for Q4 2025 stood at $117630.0, down from $147005.0 in the prior quarter.
• Over the last five years, Operating Expenses for GNOLF reached as high as $2.2 million in Q1 2023 and fell as low as $104359.0 in Q4 2021.
• Historically, Operating Expenses has averaged $458884.2 across 5 years, with a median of $159431.0 in 2021.
• Across the five-year window, Operating Expenses sank 96.33% in 2021 and jumped 711.64% in 2023, its largest moves.
• Year by year, Operating Expenses stood at $104359.0 in 2021, then jumped by 36.84% to $142801.0 in 2022, then jumped by 711.64% to $1.2 million in 2023, then jumped by 33.71% to $1.5 million in 2024, then plunged by 92.41% to $117630.0 in 2025.
• Per Business Quant data, the three most recent Operating Expenses figures were $117630.0 in Q4 2025, $147005.0 in Q3 2025, and $213951.0 in Q2 2025.